Peisen Guo

CONTACT

Lead Sponsor

The Third People's Hospital of Chengdu

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

•1. Patients aged 18 years or older who provided written informed consent
•2. Patients who schedule to undergo bariatric surgery and a liver biopsy (LB) for the investigation of suspected MASLD
•3. Patients who schedule to undergo FibroScan examination

•1. Patients with ascites or pregnant women
•2. Patients with any active implantable medical device (such as a pacemaker or defibrillator)
•3. Patients who have undergone liver transplantation
•4. Patients with cardiac failure and/or significant valvular disease
•5. Patients with haemochromatosis
•6. Patients who have refused to undergo LB or blood tests
•7. Patients with a confirmed diagnosis of active malignancy, or other terminal disease
•8. Patients participating in another clinical trial within the preceding 30 days

Related studies

NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more

NCT07265544 · Liver Neoplasm, HBV Infection, and more

NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more

NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more

NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more

Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity